Quantcast

Latest Stem cell treatments Stories

2014-09-18 12:30:29

DUBLIN, Sept. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Stem Cell Industry Report, 2014-2017" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological...

2014-09-17 16:25:43

LONDON, Sept. 17, 2014 /PRNewswire/ -- U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology,...

2014-09-16 08:32:06

WELLESLEY, Massachusetts, September 16, 2014 /PRNewswire/ -- BCC Research reveals in its new report, THE GLOBAL MARKET FOR STEM CELLS [http://www.bccresearch.com/market-research/biotechnology/stem-cells-bio035e.html ], the global market for stem cells is expected to grow to nearly $10.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 13.6%. The highest growth will be witnessed in the Americas with growth projections of $2.2 billion in 2014 to $3.9...

stem cells
2014-09-10 02:30:29

Terry Devitt, University of Wisconsin-Madison Figuring out how blank slate stem cells decide which kind of cell they want to be when they grow up — a muscle cell, a bone cell, a neuron — has been no small task for science. Human pluripotent stem cells, the undifferentiated cells that have the potential to become any of the 220 types of cells in the body, are influenced in the lab dish by the cocktail of chemical factors and proteins upon which they are grown and nurtured. Depending...

2014-09-08 23:05:50

Okyanos Heart Institute Now Accepting Qualified Heart Disease Candidates for Adult Stem Cell Treatment in New State-of-the-Art Cath Lab Freeport, Grand Bahama (PRWEB) September 08, 2014 Adult stem cell therapy for heart disease has emerged as a new treatment alternative for those living with a poor quality of life as a result of severe coronary artery disease. Okyanos is slated to begin delivering this innovative new treatment in the next several weeks, and is now screening qualified...

2014-09-05 08:24:18

Live Webcast on Wednesday, September 10, at 2:55 p.m. EST GERMANTOWN, Md., Sept. 5, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the 16(th) Annual Rodman & Renshaw Global Investment Conference on Wednesday, September 10, at 2:55 p.m. EST. Garr will provide an overview of the company's NSI-566 cell therapy clinical trials for ALS, which concluded final Phase II treatments in July, and chronic spinal cord...

2014-08-27 23:00:26

Upcoming New York Adult Stem Cell Lecture on Wednesday, September 3, 2014, at 2pm and 4pm at the City Limits Diner, at 135 Harvard Avenue, Stamford, CT 06902 New York, California (PRWEB) August 28, 2014 The Manhattan Regenerative Medicine Medical Group announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia M. Smyrniotis, Medical Director....

2014-08-19 08:30:47

Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug. 19, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its VC-01(TM) candidate cell replacement therapy to treat type 1 diabetes. The company plans to promptly initiate a Phase 1/2 clinical trial which it believes to be the first...

2014-08-19 04:22:39

JERUSALEM, August 19, 2014 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com ], a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG [http://www.novartis.com ] ("Novartis"). According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell. The option is exercisable...

2014-08-14 16:26:32

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the Global Regenerative Medicine (Stem Cell Therapy, Biomaterial and Tissue Engineering) Market (Bone and Joint) - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage,...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.